Citigroup Inc Regeneron Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 154,958 shares of REGN stock, worth $109 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

154,958

Previous 148,038 4.67%

Holding current value

$109 Million

Previous $156 Million 4.7%

% of portfolio

0.1%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $7.09 Million - $8.32 Million	6,920 Added 4.67%	154,958 $163 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $5.44 Million - $6.59 Million	-6,154 Reduced 3.99%	148,038 $156 Million
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $33.7 Million - $37.1 Million	37,371 Added 31.99%	154,192 $148 Million
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $21.4 Million - $24.4 Million	-27,665 Reduced 19.15%	116,821 $103 Million
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $560,884 - $683,939	-810 Reduced 0.56%	144,486 $119 Million
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $35 Million - $41.5 Million	49,973 Added 52.42%	145,296 $104 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $14.6 Million - $17.7 Million	-21,437 Reduced 18.36%	95,323 $78.3 Million
Q4 2022 Feb 09, 2023	BUY	$705.89 - $766.39 $5.22 Million - $5.66 Million	7,391 Added 6.76%	116,760 $84.2 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $428,755 - $541,067	-747 Reduced 0.68%	109,369 $75.3 Million
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $5.24 Million - $7.06 Million	-9,555 Reduced 7.98%	110,116 $65.1 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $11.8 Million - $13.8 Million	-19,786 Reduced 14.19%	119,671 $83.6 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $14.3 Million - $17.7 Million	26,395 Added 23.35%	139,457 $88.1 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $64.9 Million - $77 Million	113,062 New	113,062 $68.4 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account